Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 4,500 shares, a growth of 28.6% from the February 28th total of 3,500 shares. Based on an average daily trading volume, of 24,900 shares, the days-to-cover ratio is presently 0.2 days.

Apollomics Trading Down 7.1 %

APLMW stock opened at $0.01 on Monday. The firm has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.01. Apollomics has a 52-week low of $0.01 and a 52-week high of $0.03.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.